Last reviewed · How we verify
NCT07209956: PROTECT
Etude PROTECT : Prognostic Role of Tapse Evaluation in Children's bronchioliTis
NA trial testing Echocardiographic assessment of TAPSE in Bronchiolitis in 46 participants. Completed in 9 January 2023.
18 October 2022
Quick facts
| Lead sponsor | University Hospital, Bordeaux |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 46 |
| Start date | 18 October 2022 |
| Primary completion | 18 October 2022 |
| Estimated completion | 9 January 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Echocardiographic assessment of TAPSE
Conditions studied
- Bronchiolitis — all drugs for Bronchiolitis →
- Viral — all drugs for Viral →
Sponsor
University Hospital, Bordeaux
Who can join
Adults 0 Months to 2, any sex, with Bronchiolitis or Viral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this prospective study, we aim to evaluate the association between an echocardiographic marker of right ventricular systolic function, the TAPSE (Tricuspid Annular Plane Systolic Excursion), and poor outcome in patients admitted to Pediatric Intensive Care Unit (PICU) for Acute Bronchiolitis (AB).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07209956
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bronchiolitis
Currently open trials in the same condition.
- NCT07251972 — Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns · active not recruiting
- NCT06862895 — Effect of Chest Physiotherapy on Clinical Outcome of Infants With Bronchiolitis · NA · recruiting
- NCT06842238 — Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisatio · recruiting
- NCT06425107 — Point-of-Care Lung Ultrasound for Prognosis in Critically Ill Infants With Acute Lower Respiratory Tract Infection · recruiting
- NCT06108648 — Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis · Phase 4 · recruiting
Other University Hospital, Bordeaux trials
Trials by the same sponsor.
- NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
- NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
- NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
- NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
- NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07209956 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
- Last refreshed: 7 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07209956.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing